TranexamicAcidQualityChecker

Tranexamic Acid

antivirals API biologics dissolution essential medicines global market heavy metals impurities
Open selection

Tranexamic Acid Quality Checker — Antifibrinolytic Agent (Ph. Eur., USP)

ℹ️ The utility checks assay, p-toluenesulfonamide, isomers, heavy metals, dissolution profile.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! P-Toluenesulfonamide ≤0.1%. Heavy metals ≤10 ppm!

Usage:
TranexamicAcidQualityChecker.exe → demo mode
TranexamicAcidQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Assay_Percent,Melting_Point_Min,Melting_Point_Max,Isomer_Impurity_Percent,Related_Amino_Acid_Percent,P_Toluenesulfonamide_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Methanol_ppm,Residual_Solvent_Ethanol_ppm,Residual_Solvent_Water_Percent,Heavy_Metals_ppm,Sulfated_Ash_Percent,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected

Example:
TRA-SUB-2026-001,99.8,228,232,0.05,0.08,0.02,0.2,0.2,100,200,0.2,5,0.05,0.0,0.0,0.0,0.0,20,5,0,0

— WHY IS THIS NEEDED?
Tranexamic Acid — synthetic antifibrinolytic agent, lysine analog:
• Specific Synthetic Impurities: Production often involves p-toluenesulfonyl derivatives. Residual p-toluenesulfonamide is a critical impurity requiring strict control (≤0.1%). Isomers and related amino acids are also controlled.
• High Doses: Drug is used in high doses (up to several grams per day), so requirements for heavy metals (≤10 ppm) and total impurities are stricter than usual.
• Solubility: Drug is highly soluble in water, so dissolution profile for tablets should show rapid release (≥85% in 30 min).
• Moisture: Water content control is critical for powder stability.
⚠️ CRITICAL:
• Assay: 98.5–101.0%
• Melting Point: 225–235°C (with decomposition)
• Isomer Impurity: ≤ 0.2%
• Related Amino Acids: ≤ 0.2%
• P-Toluenesulfonamide: ≤ 0.1% (Critical!)
• Total Impurities: ≤ 0.5%
• Heavy Metals: ≤ 10 ppm
• Methanol: ≤ 3000 ppm
• Ethanol: ≤ 5000 ppm
• Water: ≤ 0.5%
• Dissolution: ≥ 85% in 30 min, ≥ 90% in 60 min
• Microbiology: standard limits
⚠️ Note: Utility adapted for checking specific synthetic impurities (p-toluenesulfonamide) and strict heavy metal limits due to high dosing regimen. If dissolution data absent (0), check skipped (for substance). For finished forms, slow dissolution is a critical defect.

input.csv

BatchNumber,Assay_Percent,Melting_Point_Min,Melting_Point_Max,Isomer_Impurity_Percent,Related_Amino_Acid_Percent,P_Toluenesulfonamide_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Methanol_ppm,Residual_Solvent_Ethanol_ppm,Residual_Solvent_Water_Percent,Heavy_Metals_ppm,Sulfated_Ash_Percent,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
TRA-SUB-2026-001,99.8,228,232,0.05,0.08,0.02,0.2,0.2,100,200,0.2,5,0.05,0.0,0.0,0.0,0.0,20,5,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: TranexamicAcidQualityCheckerAPI / object: Tranexamic AcidCategory: Global API expansion

1. Scope

The Tranexamic Acid Quality Checker utility is used for Tranexamic Acid. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API expansion

Tags: antivirals, API, biologics, dissolution, essential medicines, global market, heavy metals, impurities, microbiology, oncology, solid dosage, water quality

2. Execution modes

TranexamicAcidQualityChecker.exe                            → demo mode
TranexamicAcidQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • dissolution / disintegration
  • residual solvents
  • microbiology and pathogens
  • heavy metals / elemental impurities
  • pH and physicochemical parameters

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! P-Toluenesulfonamide ≤0.1%. Heavy metals ≤10 ppm!
  • Specific Synthetic Impurities: Production often involves p-toluenesulfonyl derivatives. Residual p-toluenesulfonamide is a critical impurity requiring strict control (≤0.1%). Isomers and related amino acids are also controlled.
  • High Doses: Drug is used in high doses (up to several grams per day), so requirements for heavy metals (≤10 ppm) and total impurities are stricter than usual.
  • Solubility: Drug is highly soluble in water, so dissolution profile for tablets should show rapid release (≥85% in 30 min).
  • ⚠️ CRITICAL:
  • Assay: 98.5–101.0%
  • Melting Point: 225–235°C (with decomposition)
  • Isomer Impurity: ≤ 0.2%
  • Related Amino Acids: ≤ 0.2%
  • P-Toluenesulfonamide: ≤ 0.1% (Critical!)
  • Total Impurities: ≤ 0.5%
  • Heavy Metals: ≤ 10 ppm
  • Methanol: ≤ 3000 ppm
  • Ethanol: ≤ 5000 ppm
  • Water: ≤ 0.5%
  • Dissolution: ≥ 85% in 30 min, ≥ 90% in 60 min
  • Microbiology: standard limits
  • ⚠️ Note: Utility adapted for checking specific synthetic impurities (p-toluenesulfonamide) and strict heavy metal limits due to high dosing regimen. If dissolution data absent (0), check skipped (for substance). For finished forms, slow dissolution is a critical defect.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Tranexamic Acid with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, dissolution / disintegration, residual solvents, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberTRA-SUB-2026-001mandatory field; used for batch/lot traceability
2Assay_Percentdecimal%Assay %99.8numeric value; compared with assay/purity limit from specification or method
3Melting_Point_Mindecimal°CMelting Point Min228mandatory numeric value; rule comparison is performed by the utility
4Melting_Point_Maxdecimal°CMelting Point Max232mandatory numeric value; rule comparison is performed by the utility
5Isomer_Impurity_Percentdecimal%Isomer Impurity %0.05numeric value; compared with individual or total impurity limit
6Related_Amino_Acid_Percentdecimal%Related Amino Acid %0.08numeric value; compared with individual or total impurity limit
7P_Toluenesulfonamide_Percentdecimal%P Toluenesulfonamide %0.02numeric value; checked as residual solvent against the applicable limit
8Total_Impurities_Percentdecimal%Total Impurities %0.2mandatory numeric value; rule comparison is performed by the utility
9Loss_On_Drying_Percentdecimal%Loss On Drying %0.2mandatory numeric value; rule comparison is performed by the utility
10Residual_Solvent_Methanol_ppmdecimalppmResidual Solvent Methanol ppm100numeric value; checked as residual solvent against the applicable limit
11Residual_Solvent_Ethanol_ppmdecimalppmResidual Solvent Ethanol ppm200numeric value; checked as residual solvent against the applicable limit
12Residual_Solvent_Water_Percentdecimal%Residual Solvent Water %0.2numeric value; checked as residual solvent against the applicable limit
13Heavy_Metals_ppmdecimalppmHeavy Metals ppm5numeric value; checked as elemental/metal impurity
14Sulfated_Ash_Percentdecimal%Sulfated Ash %0.05mandatory numeric value; rule comparison is performed by the utility
15Dissolution_30min_Percentdecimal%Dissolution 30min %0.0numeric value; dissolution/disintegration profile checked according to method
16Dissolution_60min_Percentdecimal%Dissolution 60min %0.0numeric value; dissolution/disintegration profile checked according to method
17Weight_Variation_RSDdecimalas specifiedWeight Variation RSD0.0mandatory numeric value; rule comparison is performed by the utility
18Friability_Percentdecimal%Friability %0.0mandatory numeric value; rule comparison is performed by the utility
19Microbial_Count_TAMCdecimalas specifiedMicrobial Count TAMC20numeric value; compared with microbiological limits
20Microbial_Count_TYMCdecimalas specifiedMicrobial Count TYMC5numeric value; compared with microbiological limits
21EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
22Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Assay_Percent,Melting_Point_Min,Melting_Point_Max,Isomer_Impurity_Percent,Related_Amino_Acid_Percent,P_Toluenesulfonamide_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Methanol_ppm,Residual_Solvent_Ethanol_ppm,Residual_Solvent_Water_Percent,Heavy_Metals_ppm,Sulfated_Ash_Percent,Dissolution_30min_Percent,Dissolution_60min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
TRA-SUB-2026-001,99.8,228,232,0.05,0.08,0.02,0.2,0.2,100,200,0.2,5,0.05,0.0,0.0,0.0,0.0,20,5,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable TranexamicAcidQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Tranexamic Acid, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "TranexamicAcidQualityChecker",
  "api": "Tranexamic Acid",
  "batchNumber": "TRA-SUB-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "TRA-SUB-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Assay_Percent",
      "value": "99.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Melting_Point_Min",
      "value": "228",
      "unit": "°C",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Melting_Point_Max",
      "value": "232",
      "unit": "°C",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Isomer_Impurity_Percent",
      "value": "0.05",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Related_Amino_Acid_Percent",
      "value": "0.08",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "P_Toluenesulfonamide_Percent",
      "value": "0.02",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Total_Impurities_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-006Insufficient dissolution or excessive disintegration timeFAIL/WARNING is produced according to method criticality.
TC-007Residual solvent above applicable limitFAIL is produced with solvent name and measured value.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Bangladesh: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Democratic Republic of the Congo: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Ethiopia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

India: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Indonesia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Kenya: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Myanmar: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Nigeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Pakistan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Africa: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Sudan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Tanzania: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Uganda: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

World API Extension QC Suite

Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.

Open